Mark Finn

Biography

Mr. Finn is the Chairman and CEO of Vantage Consulting Group. Mr. Finn serves as an independent director on the Legg Mason Partners Fund Board. He is a member of the advisory board for Auven Therapeutics, a private equity fund focused on life sciences and a board member of Cibus. He also is a co-founder of New Ventures Select, LLC, a fund focused on Royalties, and he co-founded New Ventures, LLC, an early stage venture capital fund. New Ventures LLC is the lead investor in Cibus. He served as a Trustee of the Virginia Retirement System and Chairman of its Investment Advisory Committee and as Chairman of the Investment Operations Advisory Committee for the State of Alaska. In addition, Mr. Finn was a member of the Chicago Mercantile Exchange’s Advisory Committee on Managed Futures. Mr. Finn has taught investments at the University of Virginia Darden School of Business and lectures on investments at the Mason School of Business at The College of William and Mary, where he received an MBA.

Research Interest

Medicine